Eisai Subsidiary Launches AD Diagnostic Device
This article was originally published in PharmAsia News
Executive Summary
Tokyo-based Sanko Junyaku launched DT-Navi, a diagnostic system targeting hospitals to test for progress in patients with Alzheimer's diseases